Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences

Rhea-AI Summary

Tenaya Therapeutics (NASDAQ: TNYA) announced that CEO Faraz Ali will participate in multiple key biotechnology conferences in October. Events include the Chardan 5th Annual Genetic Medicines Conference on October 4, featuring a panel discussion and a fireside chat. Ali will also speak at the Alliance for Regenerative Medicine’s Cell and Gene Meeting on October 13, followed by a company presentation. Lastly, he will present at the Jefferies Gene Therapy/Editing Summit on October 28. Tenaya focuses on innovative therapies for heart disease.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that Faraz Ali, Chief Executive Officer, is scheduled to participate in the Chardan 5^th Annual Genetic Medicines Conference, the Alliance for Regenerative Medicine’s Cell and Gene Meeting on the Mesa and the Jefferies Gene Therapy/Editing Summit in October. Details of the presentations are as follows:

Chardan 5th Annual Genetic Medicines Conference
Panel: Genetic Medicines: The Ongoing Emergence of the Heart as a Target Tissue
Date: Monday, October 4, 2021
Time: 3:00 p.m. ET

Fireside Chat
Date: Monday, October 4, 2021
Time: 4:00 p.m. ET

Alliance for Regenerative Medicine’s Cell and Gene Meeting on the Mesa
Panel: Personalizing Cardiovascular Therapies To Address The Underlying Causes Of Disease
Date: Wednesday, October 13, 2021
Time: 3:15 p.m. PT

Company Presentation
Date: Wednesday, October 13, 2021
Time: 4:45 p.m. PT

Jefferies Gene Therapy/Editing Summit
Company Presentation
Date: Thursday, October 28, 2021
Time: 11:30 a.m ET

About Tenaya Therapeutics

Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. For more information, visit www.tenayatherapeutics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210930006008/en/

For more information:

Investor Contact

Leone Patterson

Tenaya Therapeutics

IR@tenayathera.com

Media Contact:

Wendy Ryan

Ten Bridge Communications

wendy@tenbridgecommunications.com

Source: Tenaya Therapeutics

FAQ

What is Tenaya Therapeutics' stock symbol?

Tenaya Therapeutics' stock symbol is TNYA.

When will Tenaya Therapeutics CEO participate in the Chardan Genetic Medicines Conference?

CEO Faraz Ali will participate in the Chardan 5th Annual Genetic Medicines Conference on October 4, 2021.

What topics will Tenaya Therapeutics address at the Alliance for Regenerative Medicine’s conference?

At the Alliance for Regenerative Medicine’s conference on October 13, Tenaya will discuss personalizing cardiovascular therapies.

What is the date and time of Tenaya Therapeutics' presentation at the Jefferies Gene Therapy/Editing Summit?

Tenaya Therapeutics will present at the Jefferies Gene Therapy/Editing Summit on October 28, 2021, at 11:30 a.m. ET.